Drug
Odm 104
Odm 104: highest development phase Phase 1, developed by Orion Corporation. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Orion Corporation
Trials
| Drug | Phase | Indication |
|---|---|---|
| ODM-104 NCT04571996 | Phase 1 | CNS Disease |
| ODM-104 NCT01840423 | Phase 1 | Healthy |
Latest
No recent events.
Follow Odm 104 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.